US CAR-T Cell Therapy Market 2030: Outpatient Treatment Models and Cellular Therapy Care Pathways
Changes in treatment delivery models are creating new considerations for the US CAR-T Cell Therapy Market. Healthcare providers are evaluating how patient assessment, lymphodepletion, infusion, monitoring, and follow-up can be coordinated across specialized oncology networks. Expansion of appropriate outpatient or hybrid care models may require enhanced monitoring capabilities and rapid access...
0 Comments 0 Shares 9 Views 0 Reviews